| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2024 |
| Trial ID | NCT03758417 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LCAR-B38M |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma |
| Year | 2018 |
| Country | China |
| Company sponsor | Nanjing Legend Biotech Co. |
| Other ID(s) | CR108494|68284528MMY2002 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||